Adial PharmaceuticalsADIL
13F holders, Q4 2025 (December 31)23holders +7
8new positions
1sold out
1famous investor
$0.22avg. 13F price*
At the end of Q4 2025, 23 institutions reported holding Adial Pharmaceuticals Inc. (ADIL) in their 13F filings, up 7 from Q3 2025. 8 opened new positions and 1 sold out. The largest holders were Armistice Capital, LLC ($562K), Citadel Advisors ($48K) and Vanguard Group Inc. ($34K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Adial Pharmaceuticals Inc.
- CUSIP
- 00688A205
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $609K |
| Exits | 1 | $3K |
All 13F filers, Q3 2025 → Q4 2025: 2,957,569 shares bought and 29,431 shares sold, net +2,928,138 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Armistice Capital, LLC | 0.01% | New | 2,554,442 | $562K |
| Citadel Advisors | 0.00% | Add +52.7% | 219,621 | $48K |
| Vanguard Group Inc. | 0.00% | No change | 156,024 | $34K |
| Geode Capital Management, LLC | 0.00% | Reduce -5.1% | 155,745 | $34K |
| Jane Street Group, LLC | 0.00% | Add +887.3% | 121,841 | $27K |
| Northern Trust Corp. | 0.00% | New | 65,979 | $15K |
| Virtu Financial LLC | 0.00% | New | 63,827 | $14K |
| XTX Topco Ltd | 0.00% | New | 52,097 | $11K |
| Manchester Capital Management LLC | 0.00% | No change | 48,097 | $11K |
| BlackRock, Inc. | 0.00% | No change | 27,770 | $6K |
| StoneX Group Inc. | 0.00% | New | 19,451 | $4K |
| Two Sigma Securities, LLC | 0.00% | Add +33.0% | 17,074 | $4K |
| Susquehanna International Group, LLP | 0.00% | New | 12,087 | $3K |
| Private Management Group Inc. | 0.00% | No change | 10,000 | $2K |
| UBS Group AG | 0.00% | Reduce -51.1% | 9,167 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -2.1% | 1,341 | $295 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -17.1% | 1,158 | $255 |
| Bank of America Corp. | 0.00% | Add +12.6% | 205 | $45 |
| Wells Fargo & Company | 0.00% | No change | 160 | $35 |
| Harbour Investments, Inc. | 0.00% | New | 99 | $22 |
| Abound Wealth Management | 0.00% | No change | 27 | $6 |
| Morgan Stanley | 0.00% | No change | 9 | $2 |
| Citigroup Inc. | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is ADIL's weight in each manager's 13F, not the share of Adial Pharmaceuticals Inc. the manager owns.